RARE DISEASERESEARCH ATLAS

ORPHA:99885

Isolated permanent neonatal diabetes mellitus

medium confidenceDisorder

Also known as: Isolated PNDM

Publications

61

45.7th percentile

Trials

2

Interventional, condition-specific

Researchers

387

Distinct authors in sample

Gene link

ABCC8, GATA4, HNF1B

Strong

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

Permanent diabetes mellitus (PNDM) is a monogenic form of diabetes (NDM) characterized by persistent hyperglycemia within the first 12 months of life in general, requiring continuous insulin treatment.

How rare: 1-9 / 1 000 000 — roughly one to nine people per million. In a city the size of Kolkata, perhaps a few dozen.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (2)

PNDM · monogenic diabetes of infancy

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedPresent

    Strong — ABCC8, GATA4, HNF1B, INS, MNX1…

  2. LiteraturePresent

    61 matched papers (33 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    2 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (ABCC8, GATA4, HNF1B…).

GenCC classification: Strong.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

61

61 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

61 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

33 in the last 10 years · medium confidence · 45.7th percentile (publications denominator)

Phrase hits: 46 · MeSH hits: 15

Open Europe PMC search

Who's working on it?

387

Distinct author names in 61 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Ellard S11 papers · 2022

    Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX2 5DW, UK.

    Papers in Europe PMC
  2. 02
    Hattersley AT8 papers · 2022

    Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX2 5DW, UK. Electronic address: a.t.hattersley@exeter.ac.uk.

    Papers in Europe PMC
  3. 03
    Barbetti F7 papers · 2024

    San Raffaele Biomedical Park Foundation and Bambino Gesù Pediatric Hospital and Department of Internal Medicine, University of Tor Vergata, Rome, Italy.

    Papers in Europe PMC
  4. 04
    De Franco E7 papers · 2025

    Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX2 5DW, UK.

    Papers in Europe PMC
  5. 05
    Flanagan SE7 papers · 2023

    Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter EX2 5DW, UK.

    Papers in Europe PMC
  6. 06
    Rubio-Cabezas O5 papers · 2014

    Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, UK.

    Papers in Europe PMC
  7. 07
    Colombo C4 papers · 2012

    Laboratory of Molecular Endocrinology and Metabolism, Bambino Gesù Children's Hospital, Scientific Institute and Department of Internal Medicine, University of Tor Vergata, Rome, Italy.

    Papers in Europe PMC
  8. 08
    Iafusco D4 papers · 2012

    Department of Pediatrics, Second University of Naples, Italy.

    Papers in Europe PMC
  9. 09
    Bonfanti R3 papers · 2012

    Department of Pediatrics, San Raffaele Hospital and Scientific Institute, Milan, Italy.

    Papers in Europe PMC
  10. 10
    Deeb A3 papers · 2024

    Pediatric Endocrine Division, Sheikh Shakhbout Medical City and College of Medicine and Health Science, Khalifa University, Abu Dhabi, UAE.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

2

interventional trials for this specific condition

2 interventional trials matched this specific condition name; none in our sample are currently recruiting. 2 trials are registered for neonatal diabetes mellitus, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

2 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 82.4th percentile).

medium confidence · 82.4th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

2 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Broader category: neonatal diabetes mellitus

2

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

None of the matched observational studies is currently listed as recruiting.

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Isolated permanent neonatal diabetes mellitus" OR "Isolated PNDM" OR "monogenic diabetes of infancy" OR "monogenic diabetes of the infancy"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Diabetes Mellitus, Permanent Neonatal

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Isolated permanent neonatal diabetes mellitus" OR "Isolated PNDM" OR "monogenic diabetes of infancy" OR "monogenic diabetes of the infancy" OR "Diabetes Mellitus, Permanent Neonatal" OR "ABCC8" OR "GATA4" OR "HNF1B" OR "INS" OR "MNX1" OR "NEUROG3" OR "PDX1" OR "PTF1A" OR "SLC2A2"

Recall-expansion terms: ABCC8, GATA4, HNF1B, INS, MNX1, NEUROG3, PDX1, PTF1A, SLC2A2

Interventional trials matched via: recall-expansion (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 2 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"neonatal diabetes mellitus"

Query health: ok — strategies attempted: phrase, mesh, recall-expansion; with hits: phrase, mesh, recall-expansion

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: PNDM

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T06:29:25.622Z